Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1422959A Secondary lymphoid chemotactic factor SLC preparation method
06/11/2003CN1422869A Diphtherin-gonadoliberin chimeric protein
06/11/2003CN1422868A Receptor targeting chimeric toxin with junctional sequence
06/11/2003CN1422866A Effective renaturation liquid of human interferon inclusion body comprising D-sorbiol and renaturation method
06/11/2003CN1422865A Effective renaturation liquid of recombinant human interon inclusion body and renaturation method
06/11/2003CN1422862A 3,6 branched manno oligose structure used as medicine and its preparation method
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422642A Series Chinese medicinal composition for treating tumor
06/11/2003CN1422641A Medicine for treating cancerous thoracoascites and preparation method
06/11/2003CN1422640A Medicine for treating lung cancer and its preparation method
06/11/2003CN1422628A Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia
06/11/2003CN1422619A Lipid composition of high non-soluble platinum matches and lipid body
06/11/2003CN1422618A 9-nitrocamptothecin solid dispersant and preparation method
06/11/2003CN1422617A Integerrimine liposome gel preparation and preparing method
06/11/2003CN1422612A Nano-grade medicine controlled-releasing technology and preparation and use for viformicoid preparation
06/11/2003CN1111166C Water soluble cephalotaxin phosphorus polyaminoacid ester or its salt, pharmaceutical compositions contg. same, and pharmaceutical use thereof
06/11/2003CN1111162C Artemisinin derivatives, method for preparation thereof and pharmaceutical compositions containing the same
06/11/2003CN1111160C Dibenzylisoquinoline alkaloids and medicinal composition and its use
06/11/2003CN1111071C Vaccines containing saponin and sterol
06/11/2003CN1111044C Process for preparing garlic injection
06/11/2003CN1111041C Plaster for treating cancer and tumor
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer
06/10/2003US6576675 Such as 4-fluorostyryl-4-iodobenzylsulfone; targeting receptor tyrosine kinases
06/10/2003US6576660 Methods and compositions for regulation of 5-α-reductase activity
06/10/2003US6576658 Compositions and uses of dictyostatin compounds
06/10/2003US6576655 To produce polymers; cancer therapy
06/10/2003US6576651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576638 Use of substance P antagonists in the treatment of the adenocarcinomas
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576624 Administering domperidone or pimozide jointly with miltefo-sine; reducing side effect of decrease in body weight
06/10/2003US6576621 Preparation of thioarabinofuranosyl compounds and use thereof
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576612 Intravenous administration of an alpha halogen acryloyl distamycin derivative
06/10/2003US6576609 Methods and compositions for generating angiostatin
06/10/2003US6576466 Activation; separation
06/10/2003US6576464 Methods for providing differentiated stem cells
06/10/2003US6576440 Treating a wound with an invasion inducing agent such as peptides containing PHSRN sequence
06/10/2003US6576268 Biologically active fraction of vegetable melanin, process for its production and its use
06/10/2003US6576261 Potentiation of inclusion complex formation of cyclodextrin derivatives
06/10/2003US6576234 Reovirus for the treatment of neoplasia
06/10/2003CA2265708C Lipoxin compounds and their use in treating cell proliferative disorders
06/10/2003CA2204437C Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2191795C Antisense oligonucleotide modulation of raf gene expression
06/10/2003CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046581A2 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers
06/05/2003WO2003046578A2 Method for the assessment and prognosis of sarcoidosis
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046204A2 Humanized collagen antibodies and related methods
06/05/2003WO2003046189A1 Flavivirus vaccine delivery system
06/05/2003WO2003046185A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003WO2003046182A1 Human glioma antigen originating in testis
06/05/2003WO2003046181A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells
06/05/2003WO2003046164A1 Regulation of human prolyl 4-hydroxylase
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045997A2 Fusion proteins containing tlp peptides
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045973A2 Peptides with growth inhibitory action
06/05/2003WO2003045972A1 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17α-ALKYL-17β-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS
06/05/2003WO2003045971A2 Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
06/05/2003WO2003045962A1 Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions
06/05/2003WO2003045953A1 Crystals of taxane derivative and process for their production
06/05/2003WO2003045952A2 Condensed camptothecins as antitumor agents
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045939A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/05/2003WO2003045929A1 Bicyclic derivative, process for producing the same, and use
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045907A2 Sir2 products and activities
06/05/2003WO2003045901A2 Guanidine derivatives
06/05/2003WO2003045893A1 Double esters
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045456A1 Process for coating a surface of a stent
06/05/2003WO2003045429A2 Anti-t cell immunotoxin fusion protein and its therapeutic use
06/05/2003WO2003045428A2 Use of a technically modified cell as a vaccine for treating tumoral disease
06/05/2003WO2003045427A2 Pharmaceutical composition for inducing an immune response in a human or animal
06/05/2003WO2003045420A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003WO2003045414A2 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections
06/05/2003WO2003045405A2 Lactic acid bacteria and their use for treating and preventing cancer
06/05/2003WO2003045404A2 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045372A1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
06/05/2003WO2003045369A2 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
06/05/2003WO2003045367A1 Angiogenesis inhibitor
06/05/2003WO2003045334A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045328A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003WO2003045326A2 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
1 ... 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 ... 2211